Clinical Trial Update: A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing MB09 to Prolia in postmenopausal osteoporosis completed; results on efficacy, PK/PD, safety, and immune measurements have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• MB09 (denosumab)
• Prolia (denosumab)

Snippet

Sponsor: mAbxience Research S.L. | Conditions: Postmenopausal Women With Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2025-03-21